Characterization of human DAAO variants potentially related to an increased risk of schizophrenia

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 3, 2013, Pages 400-410

  Caldinelli, Laura ^a   Sacchi, Silvia ^a   Molla, Gianluca ^a   Nardini, Marco ^b   Pollegioni, Loredano ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

D Amino acid oxidase; D Serine; Enzyme variants; Neurotransmission; Schizophrenia

Indexed keywords

CHLORPROMAZINE; DEXTRO AMINO ACID OXIDASE;

APOPTOSIS; ARTICLE; BACTERIAL CELL; BINDING AFFINITY; CANCER CELL; CELL VIABILITY; CELLULAR DISTRIBUTION; CHROMOSOME PAIRING; CIRCULAR DICHROISM; COMPLEX FORMATION; CONTROLLED STUDY; CYTOPLASM; DISEASE PREDISPOSITION; ENZYME ACTIVITY; ENZYME SUBSTRATE; ESCHERICHIA COLI; GLIOBLASTOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; NONHUMAN; OXYGEN CONSUMPTION; POLYACRYLAMIDE GEL ELECTROPHORESIS; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN QUATERNARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS; SUBSTITUTION REACTION; THERMOSTABILITY; WILD TYPE;

APOPTOSIS; BLOTTING, WESTERN; CARRIER PROTEINS; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; CHLORPROMAZINE; CIRCULAR DICHROISM; D-AMINO-ACID OXIDASE; ENZYME STABILITY; FLAVIN-ADENINE DINUCLEOTIDE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KINETICS; MICROSCOPY, CONFOCAL; MODELS, MOLECULAR; MUTANT PROTEINS; MUTATION, MISSENSE; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; RISK FACTORS; SCHIZOPHRENIA; SERINE; TEMPERATURE;

SYNAPSIS;

EID: 84872246445     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.11.019     Document Type: Article

References (36)

1. Pollegioni L., Piubelli L., Sacchi S., Pilone M.S., Molla G. Physiological functions of d-amino acid oxidases: from yeast to humans. Cell. Mol. Life Sci. 2007, 64:1373-1394.
2. Mothet J.P., Parent A.T., Wolosker H., Brady R.O., Linden D.J., Ferris C.D., Rogawski M.A., Snyder S.H. d-Serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:4926-4931.
3. Mustafa A.K., Kim P.M., Snyder S.H. d-Serine as a putative glial neurotransmitter. Neuron Glia Biol. 2004, 1:275-281.
4. Schell M.J. The N-methyl d-aspartate receptor glycine site and d-serine metabolism: an evolutionary perspective. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2004, 359:943-964.
5. Martineau M., Baux G., Mothet J.P. d-Serine signalling in the brain: friend and foe. Trends Neurosci. 2006, 29:481-491.
6. Pollegioni L., Sacchi S. Metabolism of the neuromodulator d-serine. Cell. Mol. Life Sci. 2010, 67:2387-2404.
7. Fossat P., Turpin F.R., Sacchi S., Dulong J., Shi T., Rivet J.M., Sweedler J.V., Pollegioni L., Millan M.J., Oliet S.H., Mothet J.P. Glial d-serine gates NMDA receptors at excitatory synapses in prefrontal cortex. Cereb. Cortex 2012, 22:595-606.
8. Baumgart F., Rodríguez-Crespo I. d-Amino acids in the brain: the biochemistry of brain serine racemase. FEBS J. 2008, 275:3538-3545.
9. Wolosker H. Serine racemase and the serine shuttle between neurons and astrocytes. Biochim. Biophys. Acta 2011, 1814:1558-1566.
10. Panatier A., Theodosis D.T., Mothet J.P., Touquet B., Pollegioni L., Poulain D.A., Oliet S.H. Glia derived d-serine controls NMDA receptor activity and synaptic memory. Cell 2006, 125:775-784.
11. Kartvelishvily E., Shleper M., Balan L., Dumin E., Wolosker H. Neuron-derived d-serine release provides a novel means to activate N-methyl-d-aspartate receptors. J. Biol. Chem. 2006, 281:14151-14162.
12. Gustafson E.C., Stevens E.R., Wolosker H., Miller R.F. Endogenous d-serine contributes to NMDA-receptor-mediated light-evoked responses in the vertebrate retina. J. Neurophysiol. 2007, 98:122-130.
13. Oliet S.H., Mothet J.P. Regulation of N-methyl-d-aspartate receptors by astrocytic d-serine. Neuroscience 2009, 158:275-283.
14. Hashimoto K., Fukushima T., Shimizu E., Komatsu N., Watanabe H., Shinoda N., Nakazato M., Kumakiri C., Okada S., Hasegawa H., Imai K., Iyo M. Decreased serum levels of d-serine in patients with schizophrenia: evidence in support of the N-methyl-d-aspartate receptor hypofunction hypothesis of schizophrenia. Arch. Gen. Psychiatry 2003, 60:572-576.
15. Bendikov I., Nadri C., Amar S., Panizzutti R., De Miranda J., Wolosker H., Agam G. A CSF and postmortem brain study of d-serine metabolic parameters in schizophrenia. Schizophr. Res. 2007, 90:41-51.
16. Heresco-Levy U. Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia. Expert Opin. Emerg. Drugs 2005, 10:827-844.
17. Insel T.R. Rethinking schizophrenia. Nature 2010, 468:187-193.
18. Chumakov I., Blumenfeld M., Guerassimenko O., Cavarec L., Palicio M., Abderrahim H., Bougueleret L., Barry C., Tanaka H., La Rosa P., Puech A., Tahri N., Cohen-Akenine A., Delabrosse S., Lissarrague S., Picard F.P., Maurice K., Essioux L., Millasseau P., Grel P., Debailleul V., Simon A.M., Caterina D., Dufaure I., Malekzadeh K., Belova M., Luan J.J., Bouillot M., Sambucy J.L., Primas G., Saumier M., Boubkiri N., Martin-Saumier S., Nasroune M., Peixoto H., Delaye A., Pinchot V., Bastucci M., Guillou S., Chevillon M., Sainz-Fuertes R., Meguenni S., Aurich-Costa J., Cherif D., Gimalac A., Van Duijn C., Gauvreau D., Ouellette G., Fortier I., Raelson J., Sherbatich T., Riazanskaia N., Rogaev E., Raeymaekers P., Aerssens J., Konings F., Luyten W., Macciardi F., Sham P.C., Straub R.E., Weinberger D.R., Cohen N., Cohen D. Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:13675-13680.
19. Sacchi S., Bernasconi M., Martineau M., Mothet J.P., Ruzzene M., Pilone M.S., Pollegioni L., Molla G. pLG72 modulates intracellular d-serine levels through its interaction with d-amino acid oxidase: effect on schizophrenia susceptibility. J. Biol. Chem. 2008, 283:22244-22256.
20. Caldinelli L., Molla G., Bracci L., Lelli B., Pileri S., Cappelletti P., Sacchi S., Pollegioni L. Effect of ligand binding on human d-amino acid oxidase: implications for the development of new drugs for schizophrenia treatment. Protein Sci. 2010, 19:1500-1512.
21. Sacchi S., Cappelletti P., Giovannardi S., Pollegioni L. Evidence for the interaction of d-amino acid oxidase with pLG72 in a glial cell line. Mol. Cell. Neurosci. 2011, 48:20-28.
22. Labrie V., Wang W., Barger S.W., Baker G.B., Roder J.C. Genetic loss of d-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice. Genes Brain Behav. 2010, 9:11-25.
23. Molla G., Porrini D., Job V., Motteran L., Vegezzi C., Campaner S., Pilone M.S., Pollegioni L. Role of arginine 285 in the active site of Rhodotorula gracilis d-amino acid oxidase. A site-directed mutagenesis study. J. Biol. Chem. 2000, 275:24715-24721.
24. Kawazoe T., Tsuge H., Pilone M.S., Fukui K. Crystal structure of human d-amino acid oxidase: context-dependent variability of the backbone conformation of the VAAGL hydrophobic stretch located at the si-face of the flavin ring. Protein Sci. 2006, 15:2708-2717.
25. Momoi K., Fukui K., Watanabe F., Miyake Y. Molecular cloning and sequence analysis of cDNA encoding human kidney d-amino acid oxidase. FEBS Lett. 1988, 238:180-184.
26. Caldinelli L., Iametti S., Barbiroli A., Bonomi F., Piubelli L., Ferranti P., Picariello G., Pilone M.S., Pollegioni L. Unfolding intermediate in the peroxisomal flavoprotein d-amino acid oxidase. J. Biol. Chem. 2004, 279:28426-28434.
27. Molla G., Sacchi S., Bernasconi M., Pilone M.S., Fukui K., Pollegioni L. Characterization of human d-amino acid oxidase. FEBS Lett. 2006, 580:2358-2364.
28. Molla G., Bernasconi M., Sacchi S., Pilone M.S., Pollegioni L. Expression in Escherichia coli and in vitro refolding of the human protein pLG72. Protein Expr. Purif. 2006, 46:150-155.
29. Stinson R.A., Holbrook J.J. Equilibrium binding of nicotinamide nucleotides to lactate dehydrogenases. Biochem. J. 1973, 131:719-728.
30. Caldinelli L., Molla G., Sacchi S., Pilone M.S., Pollegioni L. Relevance of weak flavin binding in human d-amino acid oxidase. Protein Sci. 2009, 18:801-810.
31. Volontè F., Marinelli F., Gastaldo L., Sacchi S., Pilone M.S., Pollegioni L., Molla G. Optimization of glutaryl-7-aminocephalosporanic acid acylase expression in E. coli. Protein Expr. Purif. 2008, 61:131-137.
32. Todone F., Vanoni M.A., Mozzarelli A., Bolognesi M., Coda A., Curti B., Mattevi A. Active site plasticity in d-amino acid oxidase: a crystallographic analysis. Biochemistry 1997, 36:5853-5860.
33. Mattevi A., Vanoni M.A., Todone F., Rizzi M., Teplyakov A., Coda A., Bolognesi M., Curti B. Crystal structure of d-amino acid oxidase: a case of active site mirror-image convergent evolution with flavocytochrome b2. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:7496-7501.
34. Mitchell J., Paul P., Chen H.J., Morris A., Payling M., Falchi M., Habgood J., Panoutsou S., Winkler S., Tisato V., Hajitou A., Smith B., Vance C., Shaw C., Mazarakis N.D., de Belleroche J. Familial amyotrophic lateral sclerosis is associated with a mutation in d-amino acid oxidase. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7556-7561.
35. Sacchi S., Rosini E., Pollegioni L., Molla G. d-Amino acid oxidase as a novel class of drug for schizophrenia therapy. Curr. Pharm. Des. 2013, 19. (Ahead of print).
36. Labrie V., Wong A.H., Roder J.C. Contributions of the d-serine pathway to schizophrenia. Neuropharmacology 2012, 62:1484-1503.